TP53 and embryonal carcinoma: Embryonal carcinoma cells are hallmarked by functional p53, low levels of MDM2 (which targets p53 for proteasomal degradation), and upregulation of OCT3/4, which induce members of the proapoptotic cascade NOXA and PUMA [101].